Ruotolo, G & Howard, BV (2002) Dyslipidemia of the metabolic syndrome. Curr Cardiol Rep 4, 494–500.
Brownlee, M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813–820.
Maddux, BA, See, W, Lawrence, JC Jr, Goldfine, AL, Godlfine, ID & Evans, JL (2001) Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar concentrations of α-lipoic acid. Diabetes 50, 404–410.
Matsuoka, T, Kajimoto, Y, Watada, H, Kaneto, H, Kishimoto, M, Umayahara, Y, Fujitani, Y, Kamada, T, Kawamori, R & Yamasaki, Y (1997) Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99, 144–150.
Nakazono, K, Watanabe, N, Matsuno, K, Sasaki, J, Sato, T & Inoue, M (1991) Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 88, 10045–10048.
Ohara, Y, Peterson, TE & Harrison, DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91, 2546–2551.
Hansel, B, Giral, P, Nobecourt, E, Chantepie, S, Bruckert, E, Chapman, MJ & Kontush, A (2004) Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89, 4963–4971.
Furukawa, S, Fujita, T, Shimabukuro, M, Iwaki, M, Yamada, Y, Nakajima, Y, Nakayama, O, Makishima, M, Matsuda, M & Shimomura, I (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752–1761.
Berliner, JA & Heinecke, JW (1996) The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20, 707–727.
Goudev, A, Kyurkchiev, S, Gergova, V, Karshelova, E, Georgiev, D, Atar, D, Kehayov, I & Nachev, C (2000) Reduced concentrations of soluble adhesion molecules after antioxidant supplementation in postmenopausal women with high cardiovascular risk profiles – a randomized double-blind study. Cardiology 94, 227–232.
Azadbakht, L, Mirmiran, P, Esmaillzadeh, A & Azizi, F (2005) Dairy consumption is favorably associated with metabolic syndrome in Tehranian adults. Am J Clin Nutr 82, 523–530.
Esmaillzadeh, A, Mirmiran, P & Azizi, F (2005) Whole-grain intake and the prevalence of hypertriglyceridemic waist phenotype in Tehranian adults. Am J Clin Nutr 81, 55–63.
Riccardi, G & Rivellese, AA (2000) Dietary treatment of the metabolic syndrome – the optimal diet. Br J Nutr 83, S143–S148.
Esposito, K, Marfella, R, Citotola, M, et al. (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trail. JAMA 292, 1440–1446.
Azadbakht, L, Mirmiran, P, Esmaillzadeh, A, Azizi, T & Azizi, F (2005) Beneficial effects of a Dietary Approach to Stop Hypertension (DASH) eating plan on features of metabolic syndrome. Diabetes Care 28, 2823–2831.
Klimes, I & Sebokova, E (1995) The importance of diet therapy in the prevention and treatment of manifestations of metabolic syndrome X. Vnitr Lek 41, 136–140.
Roberts, CK, Won, D, Pruthi, S, Kurtovic, S, Sindhu, RK, Vaziri, ND & Barnard, RJ (2006) Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 100, 1657–1665.
Jenkins, DJ, Kendall, CW, Garsetti, M, et al. (2000) Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity – a controlled crossover trial. Metabolism 49, 537–543.
Vega-Lopez, S, Yeum, KJ, Lecker, JL, Ausman, LM, Johnson, EJ, Devaraj, S, Jialal, I & Lichtenstein, AH (2005) Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones. Am J Clin Nutr 81, 43–49.
Mahn, K, Borras, C, Knock, GA, et al. (2005) Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J 19, 1755–1757.
Wiseman, H, O'Reilly, JD, Adlercreutz, H, Mallet, AI, Bowey, EA, Rowland, IR & Sanders, TA (2000) Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 72, 395–400.
Engelman, HM, Alekel, DL, Hanson, LN, Kanthasamy, AG & Reddy, MB (2005) Blood lipid and oxidative stress responses to soy protein with isoflavones and phytic acid in postmenopausal women. Am J Clin Nutr 81, 590–596.
Rozenberg, S, Bosson, D, Peretz, A, Caufriez, A & Robyn, C (1988) Serum levels of gonadotrophins and steroid hormones in the post-menopause and later life. Maturitas 10, 215–224.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
Karanja, NM, Obarzanek, E, Lin, PH, et al. (1999) Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension trial. J Am Diet Assoc 99, S60–S68.
Mahan, LK & Escott-Stump, S (2004) Appendix. In Krause's Food Nutrition and Diet Therapy, 11th ed., pp. 1267–1268 [Mahan, LK and Escott-Stump, S, editors]. Philadelphia, PA: WB Saunders.
Institute of Medicine & Food and Nutrition Board (2002) Dietary Reference Intake for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: The National Academies Press.
Benzie, IF & Strain, JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239, 70–76.
Wong, SHY, Knight, JA, Hopfer, SM, Zaharia, O, Leach, CN Jr & Sunderman, FW Jr (1987) Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thio-barbituric acid adduct. Clin Chem 33, 214–220.
Franke, AA, Custer, LJ & Tanaka, Y (1998) Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 68, Suppl. 6, 1466S–1473S.
Franke, AA, Custer, LJ, Wang, W & Shi, CY (1998) HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217, 263–273.
Swain, JH, Alekel, DL, Dent, SB, Peterson, CT & Reddy, MB (2002) Iron indexes and total antioxidant status in response to soy protein intake in perimenopausal women. Am J Clin Nutr 76, 165–171.
Bricarello, LP, Kasinski, N, Bertolami, MC, Faludi, A, Pinto, LA, Relvas, WG, Izar, MC, Ihara, SS, Tufik, S & Fonseca, FA (2004) Comparison between the effects of soy milk and non-fat cow milk on lipid profile and lipid peroxidation in patients with primary hypercholesterolemia. Nutrition 20, 200–204.
Rufer, CE & Kulling, SE (2006) Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J Agric Food Chem 54, 2926–2931.
Porres, JM, Stahl, CH, Cheng, WH, Fu, Y, Roneker, KR, Pond, WG & Lei, XG (1999) Dietary intrinsic phytate protects colon from lipid peroxidation in pigs with a moderately high dietary iron intake. Proc Soc Exp Biol Med 221, 80–86.
Mitchell, JH, Gardner, PT, McPhail, DB, Morrice, PC, Collins, AR & Duthie, GG (1998) Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 360, 142–148.
Cai, Q & Wei, H (1996) Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer 25, 1–7.
Cunnane, SC, Hamadeh, MJ, Liede, AC, Thompson, LU, Wolever, TM & Jenkins, DJ (1995) Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 61, 62–68.
Cunnane, SC, Ganguli, S, Menard, C, Liede, AC, Hamadeh, MJ, Chen, ZY, Wolever, TM & Jenkins, DJ (1993) High α-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr 69, 443–453.
Roberts, LJ II & Morrow, JD (1997) The generation and actions of isoprostanes. Biochim Biophys Acta 1345, 121–135.
Kris-Etherton, PM & West, SG (2005) Soy protein with or without isoflavones: in search of a cardioprotective mechanism of action. Am J Clin Nutr 81, 5–6.
Therond, P, Bonnefont-Rousselot, D, Davit-Spraul, A, Conti, M & Legrand, A (2000) Biomarkers of oxidative stress: an analytical approach. Curr Opin Clin Nutr Metab Care 3, 373–384.
Roberts, LJ II, Montine, TJ, Markesbery, WR, Tapper, AR, Hardy, P, Chemtob, S, Dettbarn, WD & Morrow, JD (1998) Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 273, 13605–13612.
Basu, S (1998) Metabolism of 8-iso-prostaglandin F2α. FEBS Lett 428, 32–36.
Lee, CYJ, Isaac, HB, Wang, H, Huang, SH, Long, LH, Jenner, AM, Kelly, RP & Halliwell, B (2006) Cautions in the use of biomarkers of oxidative damage; the vascular and antioxidant effects of dark soy sauce in humans. Biochem Biophys Res Commum 344, 906–911.
Chirico, S, Smith, C, Marchant, C, Mitchinson, MJ & Halliwell, B (1993) Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Radic Res Commun 19, 51–57.
Prior, RL, Cao, G, Prior, RL & Cao, G (2000) Analysis of botanicals and dietary supplements for antioxidant capacity: a review. J AOAC Int 83, 950–956.
Sacks, FM, Lichtenstein, A, Van Horn, L, Harris, W, Kris-Etherton, P & Winston, M (2006) American Heart Association Nutrition Committee Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113, 1034–1044.
Sacks, FM (2005) Dietary phytoestrogens to prevent cardiovascular disease: early promise unfulfilled. Circulation 111, 385–387.
Lotito, SB & Frei, B (2006) Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 41, 1727–1746.